Anti-Mllerian hormone (AMH) level is a key indicator of ovarian reserve, reflecting the quantity of remaining eggs within a woman’s ovaries. This hormone is produced by granulosa cells of preantral and small antral follicles. The phrase pertains to methods and strategies aimed at increasing or optimizing this hormone concentration in a woman’s bloodstream, often considered in the context of fertility and reproductive health. For example, individuals undergoing fertility treatments or experiencing diminished ovarian reserve may explore approaches to enhance their AMH level.
Maintaining an optimal AMH level is crucial for women planning to conceive, as it provides insight into their reproductive potential and aids in treatment planning for assisted reproductive technologies. Higher AMH levels generally correlate with a greater number of eggs available for fertilization. The understanding and assessment of AMH levels have evolved significantly in reproductive medicine, becoming a standard diagnostic tool for evaluating ovarian function and predicting treatment outcomes. While a declining AMH level is a natural part of the aging process, understanding factors that may influence its levels can provide valuable information for family planning and reproductive health management.